Duncan Gallagher sold $31k of HCAT
director at Health Catalyst, Inc.. 4,500 shares at an average of $6.93, traded Dec 30, 2024, filed Jan 2, 2025.
Score components
- +15RoleDirector
- +5Trade size$31k at market
- 0Share of holdings soldSold 6.0% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -23.2%, 3m -43.6%, 6m -44.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001562180-25-000010, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 30, 2024 | SOpen-market sale Common Stock10b5-1 | -4,500 | $6.93 | $31k | 69,938 | Jan 2, 2025 |
Related signals
Other insiders at Health Catalyst, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | HCATbuy Health Catalyst, Inc. | Simeon Kohl Chief Executive Officer | $105k 59,000 shares | +2% | |
| 44Moderate | Health Catalyst, Inc. | Julie Larson-Green director | $128k 47,997 shares | -39% | |
| 16Weak | Health Catalyst, Inc. | Benjamin Landry General Counsel | $72k 27,425 shares | -22% | |
| 0Weak | Health Catalyst, Inc. | Benjamin Landry General Counsel | $21k 6,175 shares | -4% | |
| 0Weak | Health Catalyst, Inc. | Benjamin Landry General Counsel | $24k 6,057 shares | -4% | |
| 0Weak | Health Catalyst, Inc. | Daniel LeSueur Chief Operating Officer | $21k 5,209 shares | -2% | |
| 0Weak | Health Catalyst, Inc. | Daniel LeSueur Chief Operating Officer | $22k 5,209 shares | -2% | |
| 16Weak | Health Catalyst, Inc. | Daniel LeSueur Chief Operating Officer | $76k 16,902 shares | -7% | |
| 11Weak | Health Catalyst, Inc. | Benjamin Landry General Counsel | $63k 13,827 shares | -8% | |
| 9Weak | Health Catalyst, Inc. | Linda Llewelyn Chief People Officer | $35k 6,441 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.